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Abstract: In a previous report (M.S. Wadhwa et al. (1997)
Bioconjugate Chem. 8, 81±88), we synthesized a panel of
polylysine-containing peptides and determined that a minimal
repeating lysine chain of 18 residues followed by a tryptophan
and an alkylated cysteine residue (AlkCWK18) resulted in the
formation of optimal size (78 nm diameter) plasmid DNA
condensates that mediated ef®cient in vitro gene transfer.
Shorter polylysine chains produced larger DNA condensates and
mediated much lower gene expression while longer lysine chains
were equivalent to AlkCWK18. Surprisingly, AlkCWK18 (molecular
weight 2672) was a much better gene transfer agent than
commercially available low molecular weight polylysine
(molecular weight 1000±4000), despite its similar molecular
weight. Possible explanations were that the cysteine or
tryptophan residue in AlkCWK18 contributed to the DNA binding
and the formation of small condensates or that the
homogeneity of AlkCWK18 relative to low molecular weight
polylysine facilitated optimal condensation. To test these
hypotheses, the present study prepared AlkCYK18 and K20 and
used these to form DNA condensates and conduct in vitro gene
transfer. The results established that DNA condensates prepared
with either AlkCYK18 or K20 possessed identical particle size and
mediated in vitro gene transfer ef®ciencies that were
indistinguishable from AlkCWK18 DNA condensates, eliminating
the possibility of contributions from cysteine or tryptophan.
However, a detailed chromatographic and electrospray mass
spectrometry analysis of low molecular weight polylysine
revealed it to possess a much lower than anticipated average
chain length of dp 6. Thus, the short chain length of low
molecular weight polylysine explains its inability to form small
DNA condensates and mediate ef®cient gene transfer relative to
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Introduction
A variety of nonviral gene transfer agents have been
developed as carriers that mediate the in vitro and in vivo
transfer of foreign DNA. These generally fall into the three
categories of cationic lipids (1), synthetic polymers (includ-
ing dendrimers, polyethylenimine and peptiods) (2±5) and
peptides (6±8).
Among the peptides studied as gene delivery agents,
polylysine has been shown to bind electrostatically to DNA
and form condensates in which the peptide length in¯u-
ences particle size and the resulting gene transfer ef®ciency
(9, 10). One study found that condensed DNA particle size
decreased with decreasing polylysine chain length such that
4 kDa polylysine produced 20±30 nm DNA condensates
whereas 224 kDa polylysine resulted in 120±300 nm DNA
condensates (9). A more recent study reported that 27 kDa
polylysine forms 2-mm diameter particles that are poor
mediators of gene transfer relative to other cationic
polymers (10).
A further complication arises during the covalent attach-
ment of effector molecules to polylysine, such as carbohy-
drates, proteins or polyethylene glycol, to prepare DNA
carrier molecules capable of achieving cell type selective
targeting (11±15). The chemical derivatization of polydis-
perse polylysine further increases the heterogeneity of these
carrier molecules, contributing to the variable performance
of the resulting DNA carrier formulation (16). Conse-
quently, homogenous peptide carriers have the advantage
of precise chemical control during the synthesis of con-
jugates and formulation with plasmid DNA resulting in
greater reproducibility during in vitro and in vivo gene
transfer.
We have previously synthesized DNA-condensing pep-
tides composed of cysteine, tryptophan and 3±36 residues of
lysine in an attempt to de®ne the minimal polylysine chain
length needed to mediate ef®cient gene transfer (17).
According to this design, the cysteine residue served as a
speci®c functional group for ligand attachment and the
tryptophan afforded a hydrophobic chromophore to aid in
high-performance liquid chromatography (HPLC) puri®ca-
tion. Detailed analysis of these peptides established that a
continuous sequence of 18 lysines was suf®cient to
condense plasmid DNA into 78 nm particles, whereas
shorter polylysine chains exhibited weaker af®nity and
resulted in larger (200±2000 nm) DNA condensates which
were inferior in mediating in vitro gene expression (17).
During the course of this study, we found that commercially
available low molecular weight (LMW) polylysine (1000±
4000 Da) formed much larger condensates and failed to
mediate signi®cant gene expression. It was suggested that,
in addition to polylysine chain length, the insertion of an
aromatic amino acid may contribute to the DNA-binding
af®nity and the formation of small condensates through
intercalation.
Several studies have previously observed enhanced pep-
tide binding to DNA through intercalation of aromatic
amino acid residues (18±20). NMR experiments demon-
strated that a synthetic peptide (YSPTSPSY) positioned two
tyrosine residues to simultaneously intercalate with DNA
to enhance its binding af®nity (18). Likewise, the chirality
and position of an aromatic amino acid within a peptide was
also found to in¯uence the intercalation and the binding
af®nity to DNA (19). Furthermore, the number of aromatic
amino acids correlated with the degree of intercalation into
DNA such that peptides containing . 30% aromatic amino
acids had higher af®nity for DNA than polylysine (20).
In the present study we correlated the relative DNA-
binding af®nity, particle size and the resulting gene transfer
ef®ciency for several homogenous peptides with and with-
out aromatic residues. The results rationalize our earlier
observations on LMW polylysine and help to further
establish the optimal size and composition of DNA-
condensing peptides for nonviral gene delivery.
Experimental Procedures
N-terminal Fmoc-protected amino acids, and all other
reagents for peptide synthesis, were obtained from Advanced
ChemTech (Lexington, KY, USA). Minimum essential
media (MEM), dithiothreitol (DTT), iodoacetic acid and
LMW polylysine (MW 1000±4000, Lot #14H5526) were
purchased from Sigma Chemical Co. (St. Louis, MO, USA).
Ethanedithiol (EDT) and N,N-dimethylformamide were
AlkCWK18 DNA condensates. These experiments further
emphasize the need to develop homogenous low molecular
weight carrier molecules for nonviral gene delivery.
Abbreviations: DIC, diisopropylcarbodiimide; DTT, dithiothreitol;
EDT, ethanedithiol; ES-MS, electrospray mass spectrometry; FBS,
fetal bovine serum; HBM, Hepes-buffered mannitol; HOBt,
9-hydroxybenzotriazole; HPLC, high-performance liquid
chromatography; LB, Lurai-Bertani; LMW, low molecular weight;
MEM, minimal essential media; MW, molecular weight; NMR,
nuclear magnetic resonance; RLU, relative light units; SFM,
serum-free media; TFA, tri¯uoroacetic acid.
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purchased from Aldrich Chemical Co. (Milwaukee, WI,
USA). Tri¯uoroacetic acid (TFA) was purchased from Fisher
Scienti®c (Pittsburgh, PA, USA). Luria-Bertani (LB) media,
LB agar, d-luciferin and luciferase from Photinus pyralis
(EC1.13.12.7) were obtained from Boehringer-Mannheim
(Indianapolis, IN, USA). HepG2 cells were from the
American Type Culture Collection (Rockville, MD, USA).
Inactivated `quali®ed' fetal bovine serum (FBS) were from
Gibco BRL (Grand Island, NY, USA). Bradford reagent was
purchased from Bio-Rad (Hercules, CA, USA) and thiazole
orange was a gift from Beckton-Dickinson Immunocyto-
metry Systems (San Jose, CA, USA). The 5.6 kb plasmid
pCMLV encoding the reporter gene luciferase under the
control of the cytomegalovirus promoter was a gift from Dr
M. A. Hickman at the University of California, Davis (21).
Peptide synthesis was performed on a computer-interfaced
Model 90 Advanced ChemTech solid-phase peptide synthe-
sizer (Lexington, KY, USA). Peptide puri®cation was
performed using a semipreparative (10 mm) C18 reverse
phase (RP)-HPLC column and cation exchange chromato-
graphy was performed using an analytical (5 mm)
400VHP575 cationic exchange column from Vydac
(Hesperia, CA, USA). HPLC was performed using a
computer-interfaced HPLC and fraction collector from
ISCO (Lincoln, NE, USA).
Peptide synthesis and characterization
CWK18, CYK18 and K20 were synthesized using standard
Fmoc procedures with 9-hydroxybenzotriazole (HOBt) and
diisopropylcarbodiimide (DIC) couplings followed by N-
capping with acetic anhydride after each round of coupling.
The N-terminal Fmoc group was purposely left on K20 at the
completion of the synthesis to enhance puri®cation (22).
Peptides were cleaved from the resin and side-chain
protecting groups were removed by 1 h reaction with
TFA : EDT : water (95 : 2.5 : 2.5 v/v/v) for the cysteine-
containing peptides and TFA : water (95 : 5 v/v) for K20.
CWK18 was puri®ed as described previously (17). CYK18 was
puri®ed by injecting 3 mmol onto a Vydac C18 RP-HPLC
column (2 3 25 cm) eluted at 10 mL/min with 0.1% TFA
and a gradient of 5±20% acetonitrile over 30 min while
monitoring absorbance at 274 nm. The major peptide peak
eluting at 21 min was collected and pooled from multiple
runs, concentrated by rotary evaporation, lyophilized and
stored dry at ± 208C. The puri®ed peptide was dissolved in
0.1% TFA (degassed with N2) and quanti®ed by absorbance
(CYK18; e280nm = 1330 m
±1/cm) to determine the isolated
yield which was typically 40%.
CWK18 and CYK18 were alkylated with iodoacetic acid by
adding 50 mmol of dithiothreitol and 250 mmol of iodoacetic
acid to 2.5 mmol of peptide in 1.5 mL of 50 mm Tris (pH 7.5)
buffer and reacted at room temperature for 1 h. Each
alkylated peptide was puri®ed on RP-HPLC resulting in
. 95% purity and then analyzed by electrospray mass
spectroscopy (ES-MS) by infusing a 5-nmol/mL solution of
peptide prepared in 50 : 46 : 4% (v/v) acetonitrile : water : -
acetic acid into the source of a VG (Micromass) Platform
single quadrapole mass spectrometer (0±3000 m/z) operated
in the positive ion mode. A mass of 2671.4obs/2670.8calc
and 2650.1obs/2649.5calc was determined for (alkylated)
AlkCWK18 and (alkylated) AlkCYK18, respectively.
Fmoc-K20 was puri®ed by injecting 3 mmol onto a
semipreparative Vydac C18 RP-HPLC column (2 3 25 cm)
eluted isocratically at 10 mL/min with 16% acetonitrile
while detecting by absorbance at 260 nm. The product peak
eluting at 23 min was collected and concentrated to dryness.
The N-terminal Fmoc was removed by reacting the peptide
with 5% v/v triethylamine for 6 h at room temperature (22).
Following ether extraction, the peptide was puri®ed to
homogeneity on preparative HPLC by injecting 3 mmol onto
a semipreparative RP-HPLC column eluting isocratically at
10 mL/min with 0.05% TFA and 5% acetonitrile while
monitoring absorbance at 214 nm. The product peak eluting
at 22 min was pooled from multiple runs, dried and
dissolved in 0.1% TFA. The purity of K20 was also . 95%
as determined from cation exchange HPLC analysis as
described below. The concentration of a K20 stock solution
was determined by ¯uorescamine analysis (23) using
AlkCWK18 as a primary standard which determined the
yield of K20 from the synthesis to be 69%. The mass of K20
was determined to be 2583.0obs/2581.4calc by ES-MS as
described above.
The concentration of a stock solution of LMW polylysine
(1000±4000, HBr salt form) was also established using
AlkCWK18 as a calibrator for ¯uorescamine analysis.
LMW polylysine was analyzed by injecting 12 nmol onto a
cation-exchange column (Vydac 400 V HP575) eluted at
1 mL/min with a sodium chloride gradient of 0.1±1.5 m over
30 min while detecting the eluting peaks by absorbance at
214 nm. The chromatographic drift resulting from gradient
elution was corrected by subtracting a blank.
DNA condensation and gene expression
Peptide DNA condensates were prepared at a ®nal DNA
concentration of 20 mg/mL and at a peptide/DNA stoichio-
metry varying from 0.1 to 1.5 nmol of peptide per mg of DNA
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(0.5 : 1 to 8 : 1 amine : phosphate ratio). The condensates
were formed by adding peptide (2±30 nmol) prepared in
500 mL of isotonic Hepes-buffered mannitol (HBM, 0.27 m
mannitol, 5 mm sodium Hepes, pH 7.5) to 20 mg of DNA in
500 mL HBM while vortexing, followed by equilibration at
room temperature for 30 min.
Peptide binding to DNA was monitored by a ¯uorescence
titration assay (24). A 1-mg aliquot of the peptide DNA
condensate was diluted to 1 mL in HBM containing 0.1 mm
thiazole orange. The ¯uorescence of the intercalated dye
was measured on an LS50B ¯uorimeter (Perkin-Elmer, UK)
in a microcuvette by exciting at 500 nm while monitoring
emission at 530 nm, with the slits set at 15 and 20 nm and
photomultiplier gain set to 700 V. DNA condensation was
monitored by measuring total scattered light at 908 by
setting both monochromators to 450 nm and decreasing slit
widths to 2.5 nm. Fluorescence and scattered light intensity
blanks were subtracted from all values before data analysis.
Particle size analysis was measured for peptide DNA
condensates prepared at a DNA concentration of 20 mg/mL
in HBM and at a stoichiometry of 0.8 nmol of peptide per mg
of DNA (5.5 : 1 amine : phosphate). Samples were analyzed
using a Brookhaven ZetaPlus quasielastic light-scattering
particle sizer. The mean diameter and population distribu-
tion were computed from the diffusion coef®cient using
functions supplied by the instrument.
HepG2 cells (2 3 106 cells) were plated on 6 3 35 mm
wells and grown to 40±70% con¯uency in MEM supple-
mented with 10% FBS, penicillin and streptomycin
(10 000 U/mL), sodium pyruvate (100 mm) and l-glutamine
(200 mm). Transfections were performed in MEM (2 mL per
35 mm well) with 2% FBS, with 80 mm chloroquine (25).
Peptide DNA condensates (10 mg of DNA in 0.5 mL HBM)
were added dropwise to triplicate wells. After 5 h incubation
at 378C, the media was replaced with MEM supplemented
with 10% FBS.
Luciferase expression was determined at 24 h using some
modi®cation of a published method (26). Cells were washed
twice with ice-cold phosphate-buffered saline (calcium and
magnesium free) and then treated with 0.5 mL of ice-cold
lysis buffer (25 mm Tris chloride pH 7.8, 1 mm EDTA,
8 mm magnesium chloride, 1% Triton X-100, 1 mm DTT)
for 10 min. The cell lysate was scraped, transferred to
1.5 mL micro-centrifuge tubes and centrifuged for 7 min at
13 000 g at 48C to pellet debris.
Lysis buffer (300 mL), sodium-ATP (4 mL of a 180-mm
solution, pH 7, 48C) and cell lysate (100 mL, 48C) were
combined in a test tube, brie¯y mixed and immediately
placed in the luminometer. Luciferase relative light units
(RLU) were recorded on a Lumat LB 9501 (Berthold Systems,
Germany) with 10 s integration after automatic injection of
100 mL of 0.5 mm d-luciferin (prepared fresh in lysis buffer
without DTT). The RLU were converted into fmol using a
standard curve generated by adding a known amount of the
luciferase (0.01±100 fmol with speci®c activity of 2.5 nU/
fmol) to 35 mm wells containing 40±70% con¯uent HepG2
cells. The cells were processed as described above resulting
in a standard curve with an average slope of 220 000 RLU/
fmol of enzyme. Protein concentrations were measured by
Bradford assay using bovine serum albumin as a standard
(27). The amount of luciferase recovered in each sample was
normalized to milligrams of protein and the mean and
standard deviation obtained from each triplicate are
reported.
LipofectAce2 (Gibco BRL, 1 : 2.5 w/w dimethyl diocta-
decylammonium bromide and dioleoyl phosphatidyletha-
nolamine) was used to mediate gene transfection according
to the manufacturer's instructions. The ratio of DNA to
lipofectAce was optimized for HepG2 cells. An optimal
DNA/lipofectAce ratio was achieved by dissolving 10 mg of
DNA in 100 mL of serum-free media (SFM) followed by
adding 60 mL of lipofectAce prepared in 140 mL of SFM. The
LipofectAce±DNA complex was then diluted with 1.7 mL of
SFM and used to transfect HepG2 cells for 5 h followed by
replacing the transfecting media with supplemented 10%
FBS. The cells were incubated for a total of 24 h then
harvested and analyzed for luciferase as described above.
Results and Discussion
Solid-phase synthesis of polylysine-containing peptides is
complicated by poor yields arising from the repeating
sequence and by dif®culty in puri®cation of the desired
full-length peptide. These problems can be minimized
through double coupling, end-capping, and by positioning
a hydrophobic aromatic amino acid near the N-terminus to
allow peak identi®cation on RP-HPLC, strategies that
proved successful in the synthesis of CWK18.
Consequently, substitution of tryptophan with tyrosine to
prepare CYK18 (Fig. 1) was of no greater synthetic challenge
than the synthesis of CWK18 and was viewed as a ®rst
step toward determining whether tryptophan enhanced the
binding of CWK18 to DNA. A difference in the DNA
intercalation of aromatic residue in AlkCYK18 and
AlkCWK18 could lead to differences in binding af®nity
and the resulting DNA condensate particle size. However, a
detailed comparison of the ¯uorescence quench and total
McKenzie et al . Factors in¯uencing peptide-mediated gene delivery
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light-scattering titration curves for AlkCWK18 and
AlkCYK18 indicated no signi®cant difference in their
binding to DNA (Fig. 2A, B). Each peptide fully displaced
the intercalating dye at a 1.1 : 1 amine : phosphate ratio.
The light-scattering pro®les established that each conden-
sate was fully formed at stoichiometries above a 2.5 : 1
amine : phosphate ratio. Likewise, QELS analysis of
AlkCWK18 and AlkCYK18 DNA condensates indicated
that each formed a major (. 95%) population of particles
with a mean diameter of 43 nm (Fig. 2A', B'). Thus, the
physical properties of AlkCWK18 and AlkCYK18 DNA
condensates were indistinguishable.
AlkCWK18 and AlkCYK18 DNA condensates were also
compared for in vitro gene transfer in HepG2 cells. Both
mediated essentially equivalent levels of gene expression in
the presence of chloroquine and serum which was slightly
higher than that mediated by LipofectAce in the absence of
chloroquine and serum (Fig. 3). These results suggested that
either the aromatic residue in AlkCWK18 and AlkCYK18
function equivalently or that these residues do not
signi®cantly in¯uence peptide binding, condensation and
gene transfer ef®ciency of DNA.
The further comparison of the properties of homogenous
polylysine DNA-condensing peptides required the removal
of the aromatic residue to prepare K20. However, this
complicated the isolation of the full-length peptide due to
the lack of hydrophobic chromophore during HPLC pur-
i®cation. Consequently, this obstacle was overcome while
synthesizing K20 by retaining Fmoc on the N-terminus
during the ®nal cycle of synthesis, thereby using it as
removable chromophore following RP-HPLC puri®cation.
Comparison of the ¯uorescence and total light-scattering
titration for K20 and commercially available LMW poly-
lysine established that K20 completely quenched the
¯uorescence at an amine : phosphate ratio of < 2 : 1,
while LMW polylysine bound to DNA over a broader
range and only reached an equivalent point at an amine : -
phosphate ratio of < 4 : 1 (Fig. 2C, D). In contrast, the total
Figure 1. Structure of polylysine peptides used for gene delivery. The
structure and ES-MS analysis for AlkCWK18, AlkCYK18 and K20 are
compared. Each peptide was detected as the [M + 6H]6+±[M + 9H]9+
charge state.
Figure 2. Analysis of DNA condensation with polylysine peptides. The
thiazole orange ¯uorescence intensity (open symbol) is plotted along
with the total light scattering (closed symbol) for the titration of DNA
with AlkCWK18 (A), AlkCYK18 (B) K20 (C) and LMW polylysine (D). The
QELS particle size analysis for DNA peptide condensates prepared at a
concentration of 0.8 nmol of peptide per mg of DNA (charge ratio
< 5.5 : 1) is shown for AlkCWK18 (A'), AlkCYK18 (B') K20 (C') and LMW
polylysine (D').
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light-scattering pro®le for K20 and LMW polylysine indi-
cated that each formed fully condensed DNA at an
amine : phosphate ratio above 3 : 1.
The most signi®cant difference between K20 and LMW
polylysine was the particle size of their DNA condensates.
K20 formed small DNA condensates of < 32 nm diameter
(Fig. 2C') which were comparable with those formed by
AlkCWK18 and AlkCYK18 (Fig. 2A', B'), whereas LMW
polylysine formed large DNA condensates that were
. 1 mm in diameter (Fig. 2D').
K20 and LMW polylysine DNA condensates were also
compared for their ability to transform cells in vitro. LMW
polylysine demonstrated a four-order of magnitude decrease
in mediating gene transfer in HepG2 cells relative to K20,
which was equivalent to the gene transfer ef®ciency
mediated by AlkCWK18 and AlkCYK18 (Fig. 3). From these
results, we concluded that differences in amino acid
composition cannot account for the gene transfer properties
of AlkCWK18, AlkCYK18 and K20 relative to LMW poly-
lysine.
ES-MS molecular weight analysis provided de®nitive
proof of the structure of AlkCWK18, AlkCYK18 and K20
(Fig. 1) but proved unsuccessful for characterizing the mass
of LMW polylysine. Therefore, cation-exchange chromato-
graphy was used to separate LMW polylysine into its
component peptides (Fig. 4A). Coelution of K20 with LMW
polylysine not only established the polydispersity of the
later, but also revealed its average molecular weight to be
signi®cantly lower than dp 20, since polylysines are retained
according to their number of cationic charges. This was
con®rmed by isolating the major LMW polylysine peptide
which produced an ES-MS mass of 786.5 con®rming it as dp
6 (Fig. 4B). A 10% impurity of dp 6 produced an ion
[M + 3H]3+ at m/z of 220.3 predicting a mass of 658.2
corresponding to dp 5. Since the molar absorptivity of each
polylysine peptide is dependent on the number of lysine
residues, the cation-exchange chromatograph represents a
weight average distribution analysis of the polypeptide
mixture. Thereby, dp 5, 6 and 7 are the major peptides based
both on a weight and mol basis.
The conclusion drawn from this study is that a peptide of
< 18 lysines is suf®cient to condense DNA into small
particles that mediate ef®cient gene transfer in the presence
of chloroquine. It appears that a single aromatic amino acid
does not play a signi®cant role in the ability of AlkCWK18
and AlkCYK18 to bind and condense DNA. However, LMW
polylysine does not adequately substitute for AlkCWk18,
AlkCYK18 or K20 because it possesses signi®cant hetero-
geneity and has a mean size distribution weighted towards
lower molecular weight polylysine chains which condense
DNA to form large particles. This is consistent with our
previous results, which demonstrated that LMW polylysine
Figure 4. Cation-exchange HPLC and ES-MS analysis of LMW
polylysine. The polydispersity of LMW polylysine was determined using
cation-exchange HPLC, which includes a spiked sample of K20 as
indicated in (A). ES-MS analysis of the major LMW polylysine peak
established it as dp 6 as illustrated in (B). The results con®rmed an
average chain length of 6 for LMW polylysine.
Figure 3. Gene transfer ef®ciency of peptide DNA condensates. The
gene transfer ef®ciency, as determined by luciferase expression in
HepG2 cells, is compared for peptide DNA condensates prepared at
0.8 nmol of peptide per mg of DNA (charge ratio of < 5.5 : 1) for the
peptides indicated. LipofectAce transfection is included for comparison.
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peptides (degree of polymerization (dp) 10) condense DNA,
but form large particles that are . 1 mm in size (17).
The size of DNA condensates appears to be directly
correlated to the gene transfer ef®ciency. However, an
alternative explanation is that the relative serum stability of
the condensed DNA also correlates with the gene transfer
ef®ciency. We have recently reported that weak binding
peptides possessing eight lysine residues (AlkCWK8) dis-
sociate from DNA at sodium chloride concentrations below
0.15 m (normal saline) and fail to protect DNA from
endonuclease attack in serum (28). Thus, the inef®cient
gene transfer mediated by DNA condensates prepared with
LMW polylysine could also be due to premature metabolism
of the DNA in the cell culture media during in vitro
transfection. Consequently, AlkCWK18 is a homogenous
peptide that produces both small condensates and protects
DNA from degradation in serum (26). These are important
attributes towards the development of homogenous nonviral
gene delivery agents. Future studies will demonstrate the
utility of functionalizing the cysteine residue with targeting
ligands to create homogenous LMW carrier molecules for
gene delivery.
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